Literature DB >> 24935218

Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.

Masahiko Setoguchi1,2, Yuji Hashimoto3, Taro Sasaoka4, Takashi Ashikaga4, Mitsuaki Isobe5.   

Abstract

Although there have been several studies regarding heart failure with preserved ejection fraction (HFpEF), investigations of the risk factors for readmission of Japanese patients with HFpEF remain scarce. Therefore, our goal was to identify the risk factors for readmission of Japanese patients with heart failure (HF), particularly those with HFpEF. We analyzed 310 patients who were hospitalized for the first time with HF. Preserved EF was defined EF ≥50 %, and reduced EF (rEF) was EF <50 %. The study endpoint was readmission for HF after discharge. Medical history, vital signs, electrocardiograms, chest radiographs, blood tests and echocardiograms were compared between patients with HFpEF and with HFrEF. Among the 142 patients who had HFpEF, 43 reached the endpoint within 1 year. Multivariate analysis revealed depression (HR: 7.185), high brain natriuretic peptide (BNP) levels at discharge (HR: 1.003), and dilated inferior vena cava (HR: 1.100) as independent risk factors for readmission. In contrast, 39 of the 168 patients with HFrEF reached the endpoint. Risk factors for readmission of HFrEF patients were low sodium (HR: 0.856), high blood urea nitrogen (HR: 1.045), high BNP levels at discharge (HR: 1.003) and absence of beta-blocker prescription (HR: 0.395). In conclusion, our study suggests that the predictors of HF readmission differ between HFpEF and HFrEF patients.

Entities:  

Keywords:  Depression; Heart failure with preserved ejection fraction; Inferior vena cava; Readmission

Mesh:

Year:  2014        PMID: 24935218     DOI: 10.1007/s00380-014-0532-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  30 in total

1.  Evaluation of exercise capacity using wave intensity in chronic heart failure with normal ejection fraction.

Authors:  Yoichi Takaya; Manabu Taniguchi; Motoaki Sugawara; Saori Nobusada; Kengo Kusano; Teiji Akagi; Hiroshi Ito
Journal:  Heart Vessels       Date:  2013-03       Impact factor: 2.037

2.  Outcomes in patients with heart failure with preserved ejection fraction: it is more than the heart.

Authors:  Dalane W Kitzman
Journal:  J Am Coll Cardiol       Date:  2012-03-13       Impact factor: 24.094

3.  A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.

Authors:  Douglas S Lee; Philimon Gona; Irene Albano; Martin G Larson; Emelia J Benjamin; Daniel Levy; William B Kannel; Ramachandran S Vasan
Journal:  Circ Heart Fail       Date:  2010-11-11       Impact factor: 8.790

4.  Admission, discharge, or change in B-type natriuretic peptide and long-term outcomes: data from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF) linked to Medicare claims.

Authors:  Robb D Kociol; John R Horton; Gregg C Fonarow; Eric M Reyes; Linda K Shaw; Christopher M O'Connor; G Michael Felker; Adrian F Hernandez
Journal:  Circ Heart Fail       Date:  2011-07-08       Impact factor: 8.790

5.  Rationale and design of a randomized trial to assess the effects of beta-blocker in diastolic heart failure; Japanese Diastolic Heart Failure Study (J-DHF).

Authors:  Masatsugu Hori; Akira Kitabatake; Hiroyuki Tsutsui; Hiroshi Okamoto; Kunio Shirato; Ryozo Nagai; Toru Izumi; Hiroyuki Yokoyama; Yoshio Yasumura; Yoshio Ishida; Masunori Matsuzaki; Takashi Oki; Michihito Sekiya
Journal:  J Card Fail       Date:  2005-09       Impact factor: 5.712

Review 6.  Why is depression bad for the failing heart? A review of the mechanistic relationship between depression and heart failure.

Authors:  Karen E Joynt; David J Whellan; Christopher M O'connor
Journal:  J Card Fail       Date:  2004-06       Impact factor: 5.712

7.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial.

Authors:  Salim Yusuf; Marc A Pfeffer; Karl Swedberg; Christopher B Granger; Peter Held; John J V McMurray; Eric L Michelson; Bertil Olofsson; Jan Ostergren
Journal:  Lancet       Date:  2003-09-06       Impact factor: 79.321

8.  Optimization of the use of B-type natriuretic peptide levels for risk stratification at discharge in elderly patients with decompensated heart failure.

Authors:  Maxime Cournot; Fabien Mourre; Fabienne Castel; Jean Ferrières; Sylvain Destrac
Journal:  Am Heart J       Date:  2008-03-12       Impact factor: 4.749

9.  Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).

Authors:  Liviu Klein; Barry M Massie; Jeffrey D Leimberger; Christopher M O'Connor; Ileana L Piña; Kirkwood F Adams; Robert M Califf; Mihai Gheorghiade
Journal:  Circ Heart Fail       Date:  2008-05       Impact factor: 8.790

10.  Irbesartan in patients with heart failure and preserved ejection fraction.

Authors:  Barry M Massie; Peter E Carson; John J McMurray; Michel Komajda; Robert McKelvie; Michael R Zile; Susan Anderson; Mark Donovan; Erik Iverson; Christoph Staiger; Agata Ptaszynska
Journal:  N Engl J Med       Date:  2008-11-11       Impact factor: 91.245

View more
  23 in total

1.  High serum levels of thrombospondin-2 correlate with poor prognosis of patients with heart failure with preserved ejection fraction.

Authors:  Yuichi Kimura; Yasuhiro Izumiya; Shinsuke Hanatani; Eiichiro Yamamoto; Hiroaki Kusaka; Takanori Tokitsu; Seiji Takashio; Kenji Sakamoto; Kenichi Tsujita; Tomoko Tanaka; Megumi Yamamuro; Sunao Kojima; Shinji Tayama; Koichi Kaikita; Seiji Hokimoto; Hisao Ogawa
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

2.  Impact of onset time of acute kidney injury on outcomes in patients with acute decompensated heart failure.

Authors:  Yoichi Takaya; Fumiki Yoshihara; Hiroyuki Yokoyama; Hideaki Kanzaki; Masafumi Kitakaze; Yoichi Goto; Toshihisa Anzai; Satoshi Yasuda; Hisao Ogawa; Yuhei Kawano
Journal:  Heart Vessels       Date:  2014-08-24       Impact factor: 2.037

3.  Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.

Authors:  Ryunosuke Okuyama; Junnichi Ishii; Hiroshi Takahashi; Hideki Kawai; Takashi Muramatsu; Masahide Harada; Akira Yamada; Sadako Motoyama; Shigeru Matsui; Hiroyuki Naruse; Masayoshi Sarai; Midori Hasegawa; Eiichi Watanabe; Atsushi Suzuki; Mutsuharu Hayashi; Hideo Izawa; Yukio Yuzawa; Yukio Ozaki
Journal:  Heart Vessels       Date:  2017-02-02       Impact factor: 2.037

4.  Predictors of immediate and long-term outcomes of coronary bypass surgery in patients with left ventricular dysfunction.

Authors:  Giuseppe Gatti; Luca Maschietto; Luca Dell'Angela; Bernardo Benussi; Gabriella Forti; Lorella Dreas; Petar Soso; Marco Russo; Gianfranco Sinagra; Aniello Pappalardo
Journal:  Heart Vessels       Date:  2015-07-15       Impact factor: 2.037

5.  Diabetes is a predictor of coronary artery stenosis in patients hospitalized with heart failure.

Authors:  Tsuneharu Kosuga; Kimiaki Komukai; Satoru Miyanaga; Takeyuki Kubota; Kotaro Nakata; Kenichiro Suzuki; Takayuki Yamada; Jun Yoshida; Haruka Kimura; Michihiro Yoshimura
Journal:  Heart Vessels       Date:  2015-03-31       Impact factor: 2.037

6.  Results of ACCORDIAN in ACCORD with lower blood pressure begetting lower mortality in patients with diabetes.

Authors:  Luke J Laffin; George L Bakris
Journal:  Diabetes Obes Metab       Date:  2018-02-28       Impact factor: 6.577

7.  Prognostic value of selected echocardiographic, impedance cardiographic, and hemodynamic parameters determined during right heart catheterization in patients qualified for heart transplantation.

Authors:  Wojciech Gilewski; Jarosław Pietrzak; Joanna Banach; Robert Bujak; Jan Błażejewski; Danuta Karasek; Łukasz Wołowiec; Władysław Sinkiewicz
Journal:  Heart Vessels       Date:  2017-09-22       Impact factor: 2.037

8.  Factors affecting hospital readmission heart failure patients in Japan: a multicenter retrospective cohort study.

Authors:  Takuya Umehara; Nobuhisa Katayama; Miwako Tsunematsu; Masayuki Kakehashi
Journal:  Heart Vessels       Date:  2019-09-13       Impact factor: 2.037

9.  Efficacy and safety of the early use of V2 receptor antagonists in elderly patients with decompensated heart failure.

Authors:  Ryuichi Matsukawa; Toru Kubota; Masanori Okabe; Yusuke Yamamoto; Hiroshi Meno
Journal:  Heart Vessels       Date:  2017-08-16       Impact factor: 2.037

10.  Focused cardiac ultrasound as a predictor of readmission in acute decompensated heart failure.

Authors:  Luke J Laffin; Amit V Patel; Narayan Saha; Julian Barbat; James K Hall; Matthew Cain; Kishan Parikh; Jay Shah; Kirk T Spencer
Journal:  Int J Cardiovasc Imaging       Date:  2018-02-15       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.